Join the Tolan Center for Healthcare for a conversation with Andrew Hack, AB'95, PhD'00, MD'02, Partner at Bain Capital Life Sciences, in discussion with Brian Coe, Adjunct Professor of Entrepreneurship, as part of our Healthcare Speaker Series.
As a Partner at Bain Capital Life Sciences, Andrew focuses on private equity investments in companies developing transformative medicines, medical devices, diagnostics, and life sciences tools. Previously, he was CFO of Editas Medicine, the first publicly-listed CRISPR gene editing company. He also served as a portfolio manager at Millennium Management and began his career as a securities analyst at several healthcare-focused hedge funds and investment banks.
This session will offer insights relevant to life sciences, investing, and leading organizations in the healthcare industry.
Tuesday, April 21 | 5:00 - 6:00 PM CT | Gleacher Center
Register Here >
Healthcare Speaker Series: Andrew Hack